ir.atni.com
Investor Relations : ATNWe are a publicly traded investment firm focusing on the communications and energy industries with a commitment to a disciplined investment strategy and strong return for our investors.
http://ir.atni.com/
We are a publicly traded investment firm focusing on the communications and energy industries with a commitment to a disciplined investment strategy and strong return for our investors.
http://ir.atni.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
0.4 seconds
PAGES IN
THIS WEBSITE
12
SSL
EXTERNAL LINKS
2
SITE IP
206.200.251.19
LOAD TIME
0.395 sec
SCORE
6.2
Investor Relations : ATN | ir.atni.com Reviews
https://ir.atni.com
We are a publicly traded investment firm focusing on the communications and energy industries with a commitment to a disciplined investment strategy and strong return for our investors.
ir.atni.com
Shareholder Briefcase : ATN
http://ir.atni.com/briefcase.cfm
Skip to main content. Collect, zip and download files from our Investor Relations website. Click on the briefcase icon. Located near most downloadable files throughout our IR website and use this page to manage your briefcase. You currently have no files in your Shareholder Briefcase. 500 Cummings Center, Suite 2450, Beverly, MA 01915.
Financials & Filings : ATN
http://ir.atni.com/financials.cfm
Skip to main content. ATN Reports Second Quarter and Six Month 2016 Results. 2016 Annual Letter to Stockholders. File is in Briefcase. Non-GAAP Reconciliations in 2014. File is in Briefcase. Apr 29, 2016. File is in Briefcase. Apr 28, 2015. File is in Briefcase. Feb 29, 2016. File is in Briefcase. Mar 16, 2015. File is in Briefcase. Aug 9, 2016. File is in Briefcase. May 10, 2016. File is in Briefcase. Add PDF file to Briefcase. 500 Cummings Center, Suite 2450, Beverly, MA 01915.
Investor Relations : ATN
http://ir.atni.com/index.cfm
Skip to main content. We are a global holding company with investments in communication and renewable energy companies. Through our telecom subsidiaries, we provide both wireless and wireline connectivity to residential and business customers, including a range of mobile wireless solutions, local exchange services and broadband internet services. Our renewable energy subsidiary provides distributed generation solar power to corporate, utility and municipal customers. Aug 18, 2016. Aug 8, 2016.
Atlantic Tele-Network Sets Date to Report Second Quarter 2015 Results (NASDAQ:ATNI)
http://ir.atni.com/releasedetail.cfm?ReleaseID=922536
Jul 16, 2015. File is in Briefcase. Atlantic Tele-Network Sets Date to Report Second Quarter 2015 Results. Investor Conference Call Scheduled. July 16, 2015. Atlantic Tele-Network, Inc. Nasdaq:ATNI), announced today that it will report results for the second quarter ended. June 30, 2015. Wednesday, July 29, 2015. In addition, the Company will host a conference call to discuss its second quarter results at. 9:00 am (ET) on Thursday. July 30, 2015. Thursday, July 30, 2015. Http:/ ir.atni.com. July 30, 2015.
Email Alerts Subscription : ATN
http://ir.atni.com/profile.cfm
Skip to main content. Step 1 of 3: Select Options. You may automatically receive ATN International, Inc. financial information by email. Please enter your preferences for email notifications below and click Continue to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here. Quarterly and Annual Reports. All Events and Presentations. In advance of any event. Send me the closing stock price. Current price: 65.00.
TOTAL PAGES IN THIS WEBSITE
12
ir.at.st
Athersys - Who We Are
Congestive Heart Failure (CHF). Athersys to Present at Needham Healthcare Conference on March 28. CLEVELAND, March 20, 2018 (GLOBE NEWSWIRE) - Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 17th Annual Needham Healthcare Conference at The Westin Grand Central Hotel in New York City. The presentation is scheduled . Athersys Reports Financial Results for Fourth Quarter, Full Year 2017. Athersys is a clinical-stage biotechnology...
Allegheny Technologies - Investor Relations - Investor Relations Home
The Investor Relations section provides information to current and potential stockholders, securities analysts, and anyone who is interested in the financial and operating performance of the company. This section contains a look at the company's financial performance through earnings reports, stock price and charts, annual report highlights, and Allegheny Technologies filings with the Securities and Exchange Commission. 160; 0.59. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay.
Atmel Corporation - Investors
简体中文 - Chinese (Simplified). Português (Brasil) - Portuguese (Brazil). AVR 8- and 32-bit MCUs. Buttons, Sliders and Wheels. Programmable Logic – SPLD/CPLD. Field Programmable Gate Array. Raquo; Parametric Product Selector. Infotainment / HMI / Connectivity. Safety Critical Touch Interfaces. PLC and I/O Modules. TV High Voltage Edge-Lit. Gas and Water Meters. MCU Software Library - ASF. Atmel Gallery (app store). Third-Party Support - AVR. Third-Party Support - ARM. Atmel Gallery (app store). Aug 3, 2015.
Komunikaty biznesowe | Relacje inwestorskie | ATM Grupa S.A.
ATM Grupa S.A. Podstawowe dokumenty spółki. Notowania akcji, wykresy. Historia Operacji na Akcjach. Kontakt dla Inwestorów. 3 821,000 zł. Znaczący wzrost przychodów po III kwartałach 2014 r. Kontakt dla inwestorów. Tel: 48 071 77 64 710. Fax: 48 071 77 64 701. Http:/ www.atmgrupa.pl. Publikacja Skonsolidowanego Raportu za I półrocze 2015 r. Publikacja Skonsolidowanego Raportu Kwartalnego za III kw. 2015 r. Raport bieżący nr 10/2015:. Zawarcie umowy znaczącej z Telewizją Polsat Sp. z o.o.
Investor Relations : ATN
Skip to main content. Mar 20, 2018. ATN International to Speak at Sidoti and Company Spring 2018 Conference in NYC. Mar 12, 2018. ATN Board Declares Quarterly Dividend. View all press releases. Mar 29, 2018. ATN International to Speak at Sidoti and Company Spring 2018 Conference. Mar 5, 2018. Raymond James Investor Conference March 2018. View all events and presentations. 2017 Annual Letter to Stockholders. File is in Briefcase. View all Financials and Filings. Click here to Contact Us. Day Low: 59.25.
Atossa Genetics, Inc. (ATOS)
Atossa Genetics, Inc., The Breast Health Company™, based in Seattle, WA, is focused on improving breast health through the commercialization of patented medical devices and, through its wholly-owned subsidiary, The National Reference Laboratory for Breast Health, Inc. (NRLBH), patented tests. The NRLBH is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, Washington. Aug 6, 2015. Jun 30, 2015. Sign up for email alerts. Be the first to receive breaking news. Mr Youmans br...
Investor Overview | Atricure
Skip to main content. Soft Tissue Dissection System. Left Atrial Appendage Exclusion Devices. AtriCure Product Image Gallery. AtriCure, Inc. at Canaccord 35th Annual Growth Conference. 160;at 1:00 pm ET. Q2 2015 AtriCure, Inc. Earnings Conference Call. 160;at 4:30 pm ET. 160; 0.21. 08/07/15 4:00 pm ET. Minimum 20 minute delay. Q1 Earnings Call Transcript. AtriCure Analyst Day Presentation. AtriCure Reports Second Quarter 2015 Financial Results and Updates 2015 Outlook. Revenue of $32.6 million up 22...
Corporate Information | Atwood Oceanics
Why Work at Atwood. News and Market Information. Why Work at Atwood. News and Market Information. Corporate Profile / Risk Factors. News and Market Information. As of August 14, 2015 -. Minimum 20 minute delay. Atwood Oceanics Fiscal 2015 Third Quarter Earnings Conference Call. Thursday, July 30, 2015. Current Fleet Contract Status. ATWOOD OCEANICS ANNOUNCES FISCAL 2015 THIRD QUARTER EARNINGS. Atwood Oceanics Announces Fiscal 2015 Third Quarter Earnings Conference Call. Atwood Oceanics Announces Fiscal 2...
Investor Relations - Auris Medical : development of novel pharmaceutical therapies to prevent or treat severe inner ear disorders like tinnitus and hearing loss
We at Auris Medical are dedicated to developing novel pharmaceutical therapies to protect hearing and to silence tinnitus. Auris Medical is the leading pioneer in the emerging field of cochlear (inner ear) therapies. We have two projects in advanced clinical development:. AM-101 for the treatment of acute inner ear tinnitus and AM-111 for the treatment of acute inner ear hearing loss. Auris Medical to Announce Second Quarter 2015 Financial Results and Host Conference Call on Wednesday, August 19, 2015.
International Radiators
To obtain a login, please contact us at: info@internationalradiators.be.
SOCIAL ENGAGEMENT